Drug-Induced Dyskinesia : An Electrophysiological Analysis of Dyskinesia Induced by L-Dopa and Anticholinergic Drugs

Drug-Induced Dyskinesia : An Electrophysiological Analysis of Dyskinesia Induced by L-Dopa and Anticholinergic Drugs

Bibliographic Details
Main Author:	MANO, TADAAKI
Language:	en
Published:	Nagoya University School of Medicine 1973
Online Access:	http://hdl.handle.net/2237/17288 http://www.med.nagoya-u.ac.jp/medlib/nagoya_j_med_sci/361/361.html

Similar Items

Anticholinergic Agents Can Induce Oromandibular Dyskinesia
by: Hee-Young Shin, et al.
Published: (2009-10-01)

Maladaptive synaptic plasticity in L-DOPA-induced dyskinesia
by: Qiang Wang, et al.
Published: (2016-12-01)

Striatal neuropeptides associated with L- DOPA-induced dyskinesia
by: Moheimen, Jamil
Published: (2012)

Circuit Mechanisms of L-DOPA-Induced Dyskinesia (LID)
by: Kai Yang, et al.
Published: (2021-03-01)

Mitochondrial dysfunction in the striatum: Implications for L-DOPA Induced Dyskinesia
by: Warren, Emily Booth
Published: (2018)

Drug-induced tardive dyskinesia
by: T. M. Ostroumova, et al.
Published: (2020-02-01)

Propranolol Relieves L-Dopa-Induced Dyskinesia in Parkinsonian Mice
by: Ziqing Shi, et al.
Published: (2020-11-01)

Corticostriatal Plastic Changes in Experimental L-DOPA-Induced Dyskinesia
by: Veronica Ghiglieri, et al.
Published: (2012-01-01)

Pathophysiological Mechanisms and Experimental Pharmacotherapy for L-Dopa-Induced Dyskinesia
by: Fabbrini A, et al.
Published: (2021-04-01)

Transcriptome analysis in a rat model of l-DOPA-induced dyskinesia
by: Christine Konradi, et al.
Published: (2004-11-01)

The locus coeruleus is directly implicated in L-DOPA-induced dyskinesia in parkinsonian rats: an electrophysiological and behavioural study.
by: Cristina Miguelez, et al.
Published: (2011-01-01)

Predictors of levo-dopa induced dyskinesias in Parkinson's disease
by: R T Athulya, et al.
Published: (2020-01-01)

Effect of a selective glutamate antagonist on l-dopa-induced dyskinesias in drug-naive parkinsonian monkeys
by: Abdallah Hadj Tahar, et al.
Published: (2004-03-01)

Implication of the serotoninergic systems in Parkinson's disease and L-Dopa-induced dyskinesia
by: Riahi, Golnasim
Published: (2012)

Involvement of the bed nucleus of the stria terminalis in L-Dopa induced dyskinesia
by: Matthieu F. Bastide, et al.
Published: (2017-05-01)

Striatal plasticity in L-DOPA- and graft-induced dyskinesia; the common link?
by: Daniella eRylander Ottosson, et al.
Published: (2016-02-01)

Manual tracking in Parkinson's disease : implications for L-dopa-induced dyskinesias
by: Stevenson, James
Published: (2011)

Implication of the serotoninergic systems in Parkinson's disease and L-Dopa-induced dyskinesia
by: Riahi, Golnasim
Published: (2012)

Manual tracking in Parkinson's disease : implications for L-dopa-induced dyskinesias
by: Stevenson, James
Published: (2011)

Manual tracking in Parkinson's disease : implications for L-dopa-induced dyskinesias
by: Stevenson, James
Published: (2011)

Abnormal cortical facilitation and L-dopa-induced dyskinesia in Parkinson's disease
by: Andrea Guerra, et al.
Published: (2019-11-01)

Drug-induced dyskinesias, can they be prevented?
by: Romaniuk Małgorzata, et al.
Published: (2020-06-01)

Presynaptic mechanisms of L-DOPA-induced dyskinesia: the findings, the debate, the therapeutic implications.
by: M Angela eCenci
Published: (2014-12-01)

Imbalanced Dopaminergic Transmission Mediated by Serotonergic Neurons in L-DOPA-Induced Dyskinesia
by: Sylvia Navailles, et al.
Published: (2012-01-01)

Dopamine trasporter reversal as a pathogenic mechanism for L-dopa induced dyskinesia
by: Cheng, Christina
Published: (2009)

Optogenetic activation of striatal cholinergic interneurons regulates L-dopa-induced dyskinesias
by: Tanuja Bordia, et al.
Published: (2016-07-01)

Pharmacogenetics of drug-induced dyskinesias in Parkinson's disease
by: A. A. Tappakhov, et al.
Published: (2020-02-01)

The role of the subthalamic nucleus in L-DOPA induced dyskinesia in 6-hydroxydopamine lesioned rats.
by: Asier Aristieta, et al.
Published: (2012-01-01)

Untangling cortico-striatal connectivity and cross-frequency coupling in L-DOPA-induced dyskinesia
by: Jovana eBelic, et al.
Published: (2016-03-01)

Polymorphisms of Dopamine Receptor Genes and Risk of L-Dopa–Induced Dyskinesia in Parkinson’s Disease
by: Cristoforo Comi, et al.
Published: (2017-01-01)

Role of the atypical vesicular glutamate transporter VGLUT3 in l-DOPA-induced dyskinesia
by: Giuseppe Gangarossa, et al.
Published: (2016-03-01)

GABA storage and release in the medial globus pallidus in L-DOPA-induced dyskinesia priming
by: Haruo Nishijima, et al.
Published: (2020-09-01)

Effect of rTMS in L-DOPA Induced Dyskinesias in patients with advanced Parkinson's disease
by: Butanda-Núñez Alejandra, et al.
Published: (2015-03-01)

Dopamine D3 Receptor Plasticity in Parkinson’s Disease and L-DOPA-Induced Dyskinesia
by: Kathryn Lanza, et al.
Published: (2021-03-01)

Levetiracetam Ameliorates L-DOPA-Induced Dyskinesia in Hemiparkinsonian Rats Inducing Critical Molecular Changes in the Striatum
by: Huan Du, et al.
Published: (2015-01-01)

Variations of Aripiprazole-Induced Dyskinesia Existing with Concurrent Use of Amantadine and an Anticholinergic Agent in an Elderly Patient
by: I-Wen Sun, et al.
Published: (2012-06-01)

Serotonin system implication in L-DOPA-induced dyskinesia: from animal models to clinical investigations
by: Manolo eCarta, et al.
Published: (2014-05-01)

Spontaneous locomotor activity and L-DOPA-induced dyskinesia are not linked in 6-OHDA parkinsonian rats
by: Stefania eSgroi, et al.
Published: (2014-10-01)

The pharmacological manipulation of L-DOPA-induced dyskinesia in the MPTP-treated marmoset model of Parkinson's disease
by: Banerji, Tara
Published: (2002)

Targeting the cannabinoid receptor CB2 in a mouse model of l-dopa induced dyskinesia
by: Peggy Rentsch, et al.
Published: (2020-02-01)

Cannot write session to /tmp/vufind_sessions/sess_mdktvkv0hbvubnjlnvi87bh4cm